RxDoctor Payments Data

Katherine Reynolds

Family · Utica, MINPI 1629614623

Payments from drug & device makers

$3,096in general payments, 2019–2025

Across 128 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$464
  • Novartis$373
  • Merck$344
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$252
  • Atricure, Inc.$238
  • Johnson & Johnson$195
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,99297%
  • Education$1043%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,096 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban278$326,004
XareltoRivaroxaban91$98,734
EntrestoSacubitril/Valsartan52$78,709
Repatha SureclickEvolocumab43$33,474
JardianceEmpagliflozin19$13,795
VascepaIcosapent Ethyl21$9,591
BrilintaTicagrelor16$7,558
Praluent PenAlirocumab12$5,412
Metoprolol Succinate375$4,778
Rosuvastatin Calcium160$3,447
Ranolazine ErRanolazine25$3,366
LivaloPitavastatin Calcium12$3,225
Atorvastatin Calcium363$3,001
Losartan Potassium274$2,827
Flecainide Acetate56$2,600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$326,004278 claims
Johnson & JohnsonXarelto$195$98,73491 claims
NovartisEntresto$373$78,70952 claims
Boehringer IngelheimJardiance$58$13,79519 claims
AstraZenecaBrilinta$139$7,55816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Utica

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →